Bitget App
Trade smarter
MarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ-CSL plans to convert all its plasma centers in the US to use Haemonetics equipment, driving the company's stock price to soar

BUZZ-CSL plans to convert all its plasma centers in the US to use Haemonetics equipment, driving the company's stock price to soar

路透社路透社2026/10/08 14:36
Show original

October 8 – ** Shares of medical device manufacturer Haemonetics (HAE.N) surged nearly 16% to $117.81 ** The stock hit an intraday high of $120.61, marking its highest level since early 2021 ** The company stated that CSL Plasma, a subsidiary of Australia’s CSL Group (CSL.AX), expects to transition all its U.S. plasma collection centers to using HAE’s NexSys devices and kits by the end of 2027 ** CSL has also terminated its agreement with HAE rival Terumo (Terumo 4543.T) – according to BTIG ** This transition will help HAE win back business lost since 2021, when its largest plasma client CSL announced it would not renew its U.S. supply contract ** BTIG estimates that, based on approximately $155 million in revenue HAE generated from CSL’s U.S. business in fiscal year 2024, this account could add about $0.60 per share to adjusted earnings annually, though it notes that actual revenue and profit margins remain unclear ** The brokerage maintained its “Buy” rating and raised its price target from $110 to $130, stating that the deal alleviates market share loss concerns and boosts sales growth prospects ** Including today’s gains, the stock is up 49.46% so far this year (For the convenience of non-English speakers, Reuters provides its reports in several other languages through automated translation. Because automated translation may be inaccurate or lack needed context, Reuters does not guarantee the accuracy of the automated text, which is offered purely as a reader service. Reuters accepts no liability for any damage or loss caused by the use of automated translation services.)

- ** Shares of medical device manufacturer Haemonetics (HAE.N) surged nearly 16% to $117.81

** During the session, the stock reached as high as $120.61, marking its highest level since early 2021

** The company said that CSL Plasma, a subsidiary of Australian CSL Group (CSL.AX), expects to convert all of its US plasma collection centers to HAE's NexSys devices and kits by the end of 2027

** CSL has also terminated its agreement with HAE competitor Terumo (4543.T)—BTIG

** This conversion will help HAE win back business lost since 2021, when its largest plasma customer, CSL, announced it would not renew its US supply contract

** BTIG estimates that, based on the roughly $155 million in revenue HAE got from CSL's US business in fiscal 2024, the deal could add about 60 cents per share annually to adjusted earnings, but notes that the actual revenue and margin remain unclear

** The broker maintains a "Buy" rating, raising the target price from $110 to $130, saying the deal eases concerns over market share loss and boosts sales growth prospects

** Including the day's gains, the stock is up 49.46% so far this year


(To assist non-native English speakers, Reuters has automatically translated its report into several other languages. Because automated translations may contain errors or lack certain context, Reuters does not guarantee the accuracy of translated texts, which are provided only for the convenience of readers. Reuters accepts no liability for any damages or losses resulting from the use of automated translation features.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Correction-BUZZ-Starbucks stock price drops; reports say the company is considering acquiring Chipotle Mexican Grill

Correction to point 4: The market capitalization should be approximately $39 billion for Chipotle, not Starbucks. On October 8 — Starbucks (SBUX.O) shares fell by as much as 6.66%, trading at $87.35. The Financial Times, citing people familiar with the matter, reported that the company had explored the possibility of acquiring Chipotle Mexican Grill (CMG.N) (link). The report stated that the progress of the potential acquisition remains unclear. Chipotle (CMG) has a market capitalization of about $39 billion. Chipotle (CMG) shares once surged by as much as 8.55% to $33.40. Chipotle did not immediately respond to a Reuters request for comment. As of the previous trading day's close, SBUX shares were up about 10% year-to-date, while CMG shares had fallen by 12% over the same period. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for the convenience of readers. Reuters accepts no liability for any damage or losses resulting from the use of the automated translation function.)

路透社•2026/10/08 17:26

BUZZ - Tobacco and alcohol stocks lead gains in the consumer staples sector

On October 8, Thursday, Philip Morris International (PM.N) became the top gainer in the S&P 500 Consumer Staples sector (.SPLRCS), followed by alcoholic beverage company Constellation Brands (STZ.N) and Altria Group (MO.N), both ranking among the day's biggest gainers. Shares of Philip Morris International (PM), a supplier of cigarettes and smoke-free nicotine products, rose about 4% to $200.89, set for a fourth consecutive session of gains and marking the largest single-day increase since July 16. Marlboro cigarette maker Altria gained 2.9% to $71.36. Earlier, British peer Imperial Brands (IMB.L) said it expects to meet its full-year guidance and announced a £1.5 billions ($1.98 billions) share buyback plan, as robust growth in tobacco alternatives helped offset declining cigarette sales. STZ, which produces beer, wine, and spirits, rose over 3% to $122.35 on the second trading day after releasing its quarterly report, despite several brokerages lowering their price targets. JPMorgan, however, raised its target from $133 to $136. Cetera Chief Investment Officer Gene Goldman noted on Thursday that there is “a rotation from growth stocks to defensive stocks” in the market, adding that “rising yields and wider credit spreads are putting pressure on AI and growth stocks.” He also pointed out that valuations in the sector are improving. Over the past three months, the sector has underperformed the broader S&P 500, falling 1% versus the benchmark’s 3.9% rise. Among the five S&P sectors that did not decline on Thursday, the Consumer Staples Index posted the second-largest gain, up 1.6%.

路透社•2026/10/08 17:06